Cargando…
Non-Dose-Dependent Changes in Liver Enzyme Levels of Children With Epilepsy on Treatment With Sodium Valproate
BACKGROUND: Sodium valproate (VPA) is considered as the drug of choice for the treatment of generalized epilepsy in children. Sodium Valproate may be hepatotoxic. AIM: To assess the level of derangement of liver enzymes in children with epilepsy on treatment with sodium valproate. METHODS: A cohort...
Autores principales: | Adedapo, Aduragbenro Deborah A., Demaki, Winifred Eseoghene, Lagunju, IkeOluwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180311/ https://www.ncbi.nlm.nih.gov/pubmed/32362796 http://dx.doi.org/10.1177/1559325820918445 |
Ejemplares similares
-
Cognitive function in Nigerian children with newly diagnosed epilepsy: a preliminary report
por: Lagunju, Ike Oluwa Abiola, et al.
Publicado: (2016) -
Sodium Valproate Combined With Topiramate vs. Sodium Valproate Alone for Refractory Epilepsy: A Systematic Review and Meta-Analysis
por: Ji, Zhen-Ye, et al.
Publicado: (2022) -
Measures to Mitigate Sodium Valproate Use in Pregnant Women With Epilepsy
por: Ranjith, Saanthwana, et al.
Publicado: (2022) -
Efficacy and safety of sodium valproate plus lamotrigine in children with refractory epilepsy
por: Zhang, Dongli, et al.
Publicado: (2020) -
Hypertensive urgency in a child with focal epilepsy: Is it sodium valproate induced?
por: Vijayan, Anju, et al.
Publicado: (2022)